• Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise

Log in

Start free trial
G2 Intelligence
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
FDA Watch: EU’s New IVD Regulations Could Drive More Firms to Seek FDA Approval

FDA Watch: EU’s New IVD Regulations Could Drive More Firms to Seek FDA Approval

by Ron Shinkman | Dec 5, 2024 | Essential, FDA-lca, Lab Industry Advisor

Although the timelines have been extended several times, IVDR complexity has created a concerning bottleneck in the approval process

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
FDA Watch: 2022 510(k) Lab Test Approvals Year in Review

FDA Watch: 2022 510(k) Lab Test Approvals Year in Review

by Glenn S. Demby | Jan 31, 2023 | Essential, FDA-lir, Laboratory Industry Report

Abbott and Roche garnered the lion’s share of new 510(k) lab test approvals in 2022.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here

Roche Alzheimer’s Early Detection Tests Get FDA Green Light

by Glenn S. Demby | Dec 22, 2022 | Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, FDA-dtet

In this month’s diagnostics pipeline report, Roche gets clearance for two new Alzheimer’s early detection tests.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
December 2022 FDA Watch: More Approvals in US than EU

December 2022 FDA Watch: More Approvals in US than EU

by Glenn S. Demby | Dec 1, 2022 | Essential, FDA-lir, Laboratory Industry Report

A high volume of FDA approvals for new tests and diagnostic products made up for the relatively low number of approvals in the EU.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Illumina Faces Loss of Grail, Massive Fines

Illumina Faces Loss of Grail, Massive Fines

by Glenn S. Demby | Aug 2, 2022 | News, Open Content

European Commission accuses sequencing giant of “jumping the gun” on Grail acquisition.

« Older Entries

Sign up for our free weekly Lab & Pathology Insider email newsletter

Log In

Join Now | Lost Password?
  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
Copyright © 2025 G2Intelligence.com